CEO of MSD Korea elected as KRPIA chairman.

Published: 2005-06-17 06:59:00

Updated: 2005-06-17 06:59:00

The Korea Multinationala Drug Corporation group, KRPIA, elected Mr. Mark Timney, the CEO of MSD Korea as the 7th chairman of KRPIA on June 14 succeeding Mr. Michael Richter who led the group during the past 2 years.

Mr.Timney said "I was pleased to accept the directorate's resolution for the chairmanship of the KRPIA, representing to 29 research centered global pharmaceutical corporations,...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.